Comparative hemodynamic effects of converting enzyme inhibitor and sodium nitroprusside in severe heart failure

Jan 1, 1986·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·C Hall, B E Karlberg

Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure

Jul 1, 1981·The American Journal of Medicine·W S ColucciE Braunwald

Effect of sodium nitroprusside on ventilation-perfusion mismatching in heart failure

Nov 1, 1984·Journal of the American College of Cardiology·H Z BencowitzP D Wagner

Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside

Mar 1, 1985·Journal of the American College of Cardiology·M A FiferW H Barry

Progress in vasodilator therapy for heart failure

Jun 19, 1980·The New England Journal of Medicine·J N Cohn

Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction

May 29, 2003·Critical Care Medicine·Frank WagnerRoland Hetzer

The CREST syndrome--successful reduction of pulmonary hypertension by captopril

Oct 1, 1984·Postgraduate Medical Journal·P J ProuseJ M Gumpel

Enalaprilat controls postoperative hypertension while maintaining cardiac function and systemic oxygenation after neurosurgery

Aug 1, 1995·Intensive Care Medicine·H Tohmo, M Karanko

Long-term control of congestive heart failure with captopril

Apr 21, 1982·The American Journal of Cardiology·F M FouadE E Salcedo

Angiotensin-converting enzyme inhibition in congestive heart failure: the concept

Apr 21, 1982·The American Journal of Cardiology·J N Cohn, T B Levine

Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure

Oct 1, 1982·American Heart Journal·G S FrancisJ N Cohn

Plasma norepinephrine levels in infants and children with congestive heart failure

Apr 1, 1987·The American Journal of Cardiology·R D RossS Kaplan

Hemodynamic effects of captopril in patients with severe chronic heart failure

Apr 21, 1982·The American Journal of Cardiology·T H LeJemtelE H Sonnenblick

Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure

Apr 1, 1982·The American Journal of Cardiology·G S FrancisJ N Cohn

Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure

Jan 1, 1983·The American Journal of Cardiology·M PackerM Yushak

Central and regional hemodynamic effects and neurohumoral consequences of minoxidil in severe congestive heart failure and comparison to hydralazine and nitroprusside

Oct 1, 1983·The American Journal of Cardiology·R V MarkhamB G Firth

The effect of captopril on renal, coronary, and systemic hemodynamics in patients with severe congestive heart failure

Nov 1, 1982·American Heart Journal·E R PowersP J Cannon

Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology

Dec 1, 1981·The American Journal of Cardiology·D S Goldstein

Improved right ventricular function and reduced pulmonary vascular resistance during prazosin therapy of congestive heart failure

Jul 1, 1981·The American Journal of Medicine·W S ColucciE Braunwald

The neurohumoral and hemodynamic response to orthostatic tilt in patients with congestive heart failure

May 1, 1983·Circulation·T B LevineJ N Cohn

Placebo-controlled, randomized, double-blind study of intravenous enalaprilat efficacy and safety in acute cardiogenic pulmonary edema

Sep 15, 1996·Circulation·D AnnaneP Gajdos

Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstrictor forces during vasodilator therapy

Sep 1, 1981·Circulation·M PackerR Gorlin

Immediate effects of captopril in acute left ventricular failure secondary to myocardial infarction

Oct 1, 1981·European Journal of Clinical Investigation·F BrivetJ Dormont

Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction

Jan 1, 1982·British Journal of Clinical Pharmacology·D J FitzgeraldE O'Brien

Beneficial effects of captopril in left ventricular failure in patients with myocardial infarction

Jan 1, 1982·British Journal of Clinical Pharmacology·J P BounhoureJ Puel

Pathophysiological considerations in selecting vasodilator therapy for CHF

Jan 1, 1981·Acta Medica Scandinavica. Supplementum·J N Cohn

Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure

Jan 1, 1982·British Journal of Clinical Pharmacology·S RicciG Mattioli

Captopril in congestive heart failure (author's transl)

Feb 1, 1982·Klinische Wochenschrift·G Liebau

❮ Previous

Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Comparative hemodynamic effects of converting enzyme inhibitor and sodium nitroprusside in severe heart failure

Abstract

References

The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.

Effects of sublingual nitroglycerin on resting pulmonary gas exchange and hemodynamics in man

Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside

Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure

Angiotensin converting enzyme inhibition in patients with congestive heart failure

Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation

Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin

Hemodynamic, ventilatory and blood gas changes during infusion of sodium nitroferricyanide (nitroprusside). Studies in patients with congestive heart failure

Phentolamine for vasodilator treatment of severe heart-failure

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients

Treatment of refractory heart failure with infusion of nitroprusside

Comparison of effects of angiotensin and norepinephrine on pulmonary circulation, systemic arteries and veins, and systemic vascular capacity in the dog

Citations

Plasma concentrations of angiotensin II and aldosterone during acute left ventricular failure in the dog. Effect of converting enzyme inhibition